$Nephros (NEPH.US)$ Expected to be profitable in 2025. Projected to increase sales 8-10% in 2025, accelerating to 12.5% 2026 No debt Current/Quick 4.1/2.6 (above ind avgs) Oversold/Undervalued
$Nephros (NEPH.US)$ Nephros Launches New HydraGuard 20” UltraFilter Nephros (Nasdaq: NEPH) has launched the HydraGuard 20" UltraFilter, expanding its filtration technology portfolio. The new filter offers higher-volume capacity and flow rate while removing bacteria, viruses, and endotoxins. This product enables Nephros to enter new markets, particularly medical device manufacturing and pharmaceutical production, supporting compliance with water quality standards like ANSI/AAMI ST108. The filt...
Given Ms. Krandel's notable track record and proven expertise in financial management and strategic planning, her appointment as CFO is viewed positively, providing confidence in her ability to contribute to Nephros's continued growth and financial stability.
Nephros Stock Forum
Expected to be profitable in 2025.
Projected to increase sales 8-10% in 2025, accelerating to 12.5% 2026
No debt
Current/Quick 4.1/2.6 (above ind avgs)
Oversold/Undervalued
Nephros Launches New HydraGuard 20” UltraFilter
Nephros (Nasdaq: NEPH) has launched the HydraGuard 20" UltraFilter, expanding its filtration technology portfolio. The new filter offers higher-volume capacity and flow rate while removing bacteria, viruses, and endotoxins. This product enables Nephros to enter new markets, particularly medical device manufacturing and pharmaceutical production, supporting compliance with water quality standards like ANSI/AAMI ST108.
The filt...
No comment yet